Construction and Assessment of the Quality of a Care Protocol for Insulin Use in Hospitalized Children and Adolescents

Overview

Journal Rev Bras Enferm

Specialty Nursing

Date 2025 Mar 12

PMID 40072991

Authors

Sarah Arrais de Lavor

Carla Cristina de Sordi

Vanessa de Araujo Lima Freire

Debora Lira Correia

Rhanna Emanuela Fontenele Lima de Carvalho

Fernanda Jorge Magalhaes

Sherida Karanini Paz de Oliveira

Affiliations

Soon will be listed here.

Abstract

Objectives: to develop and assess the quality of a care protocol for safe insulin use in hospitalized children and adolescents.

Methods: a methodological study developed in three stages: scoping review, protocol development, and quality assessment. The scoping review followed the JBI recommendations, using the PRISMA-ScR checklist. The protocol was constructed according to the Guide for the Construction of Healthcare Protocols, and quality assessment was carried out byjudges using AGREE II.

Results: the protocol achieved a quality rating of 94.4% in the scope and purpose domain; 90.4% in stakeholder involvement; 96.1% in rigor of development; 95.2% in clarity of presentation; 92.8% in applicability; 97.6% in editorial independence; and 92.8% for overall guideline assessment. Judges made suggestions, most of which were accepted.

Final Considerations: the protocol was constructed and assessed as a quality instrument recommended for use by healthcare professionals in the context of insulin therapy in pediatrics.

References

Alexandre N, Coluci M . [Content validity in the development and adaptation processes of measurement instruments]. Cien Saude Colet. 2011; 16(7):3061-8. DOI: 10.1590/s1413-81232011000800006. View

Kalra S, Pathan F, Kshanti I, Bay N, Nagase T, Oliveria T . Optimising Insulin Injection Techniques to Improve Diabetes Outcomes. Diabetes Ther. 2023; 14(11):1785-1799. PMC: 10570228. DOI: 10.1007/s13300-023-01460-y. View

Demir G, Er E, Atik Altinok Y, Ozen S, Darcan S, Goksen D . Local complications of insulin administration sites and effect on diabetes management. J Clin Nurs. 2021; 31(17-18):2530-2538. DOI: 10.1111/jocn.16071. View

Poppy A, Retamal-Munoz C, Cree-Green M, Wood C, Davis S, Clements S . Reduction of Insulin Related Preventable Severe Hypoglycemic Events in Hospitalized Children. Pediatrics. 2016; 138(1). PMC: 5901907. DOI: 10.1542/peds.2015-1404. View

Azar C, Allue D, Valnet-Rabier M, Chouchana L, Rocher F, Durand D . Patterns of medication errors involving pediatric population reported to the French Medication Error Guichet. Pharm Pract (Granada). 2021; 19(2):2360. PMC: 8234707. DOI: 10.18549/PharmPract.2021.2.2360. View

Kesavadev J, Saboo B, Krishna M, Krishnan G . Evolution of Insulin Delivery Devices: From Syringes, Pens, and Pumps to DIY Artificial Pancreas. Diabetes Ther. 2020; 11(6):1251-1269. PMC: 7261311. DOI: 10.1007/s13300-020-00831-z. View

Vieira T, Sakamoto V, Moraes L, Blatt C, Caregnato R . Validation methods of nursing protocols: an integrative review. Rev Bras Enferm. 2020; 73(suppl 5):e20200050. DOI: 10.1590/0034-7167-2020-0050. View

Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A . Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016; 5(1):210. PMC: 5139140. DOI: 10.1186/s13643-016-0384-4. View

. 16. Diabetes Care in the Hospital: Standards of Care in Diabetes-2024. Diabetes Care. 2023; 47(Suppl 1):S295-S306. PMC: 10725815. DOI: 10.2337/dc24-S016. View

10.

Arora S, Agrawal N, Shanthaiah D, Verma A, Singh S, Patne S . Early detection of cutaneous complications of insulin therapy in type 1 and type 2 diabetes mellitus. Prim Care Diabetes. 2021; 15(5):859-864. DOI: 10.1016/j.pcd.2021.06.004. View

11.

Kalra S, Unnikrishnan A, Prasanna Kumar K, Sahay R, Chandalia H, Saboo B . Addendum 1: Forum for Injection Technique and Therapy Expert Recommendations, India. Diabetes Ther. 2022; 14(1):29-45. PMC: 9880128. DOI: 10.1007/s13300-022-01332-x. View

12.

Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow C . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021; 372:n71. PMC: 8005924. DOI: 10.1136/bmj.n71. View

13.

Radwan M, Akbari Sari A, Rashidian A, Takian A, Abou-Dagga S, Elsous A . Appraising the methodological quality of the clinical practice guideline for diabetes mellitus using the AGREE II instrument: a methodological evaluation. JRSM Open. 2017; 8(2):2054270416682673. PMC: 5298436. DOI: 10.1177/2054270416682673. View

14.

Danne T, Phillip M, Buckingham B, Jarosz-Chobot P, Saboo B, Urakami T . ISPAD Clinical Practice Consensus Guidelines 2018: Insulin treatment in children and adolescents with diabetes. Pediatr Diabetes. 2018; 19 Suppl 27:115-135. DOI: 10.1111/pedi.12718. View

15.

Tricco A, Lillie E, Zarin W, OBrien K, Colquhoun H, Levac D . PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med. 2018; 169(7):467-473. DOI: 10.7326/M18-0850. View

16.

Jasper M . Expert: a discussion of the implications of the concept as used in nursing. J Adv Nurs. 1994; 20(4):769-76. DOI: 10.1046/j.1365-2648.1994.20040769.x. View

17.

DErrico S, Zanon M, Radaelli D, Padovano M, Santurro A, Scopetti M . Medication Errors in Pediatrics: Proposals to Improve the Quality and Safety of Care Through Clinical Risk Management. Front Med (Lausanne). 2022; 8:814100. PMC: 8795662. DOI: 10.3389/fmed.2021.814100. View

18.

Alqahtani N . Reducing potential errors associated with insulin administration: An integrative review. J Eval Clin Pract. 2022; 28(6):1037-1049. DOI: 10.1111/jep.13668. View